Search research articles
Contact Us
Filters
Showing results (31-40 of 66) with videos related to
Page
of 7
Sort By:
Nature Cardiovascular Research
|
August 28, 2024
Deubiquitinase JOSD2 improves calcium handling and attenuates cardiac hypertrophy and dysfunction by stabilizing SERCA2a in cardiomyocytes
Jibo Han, Zimin Fang, Bingjiang Han, et al.
British Journal of Pharmacology
|
March 31, 2026
The deubiquitinase YOD1 in cardiomyocytes mediates septic cardiomyopathy by deubiquitinating and thus stabilizing the NLRP3 inflammasome
Zhaozheng Zheng, Yingjie Liao, Yucheng Jiang, et al.
ESC Heart Failure
|
January 26, 2021
The prevalence, predictors, and outcomes of spontaneous echocardiographic contrast or left ventricular thrombus in patients with HFrEF
Xiaodong Zhou, Ruiyu Shi, Gaojun Wu, et al.
Theranostics
|
May 8, 2023
OTUD1 promotes pathological cardiac remodeling and heart failure by targeting STAT3 in cardiomyocytes
Mengyang Wang, Xue Han, Tianxiang Yu, et al.
EMBO Molecular Medicine
|
March 10, 2023
Macrophage DCLK1 promotes atherosclerosis via binding to IKKβ and inducing inflammatory responses
Zhuqi Huang, Sirui Shen, Xue Han, et al.
Inflammopharmacology
|
March 27, 2025
Carnosol mitigates Ang II-stimulated vascular injury and oxidative stress by directly binding to FAK and inhibiting its activation
Yucheng Jiang, Zhaozheng Zheng, JunYi Wang, et al.
Acta Pharmaceutica Sinica. B
|
April 4, 2024
Hyperglycemia activates FGFR1 <i>via</i> TLR4/c-Src pathway to induce inflammatory cardiomyopathy in diabetes
Xiong Chen, Jinfu Qian, Shiqi Liang, et al.
Acta Pharmaceutica Sinica. B
|
June 9, 2025
Deubiquitinase USP13 alleviates doxorubicin-induced cardiotoxicity through promoting the autophagy-mediated degradation of STING
Liming Lin, Jibo Han, Diyun Xu, et al.
Clinical and Translational Medicine
|
February 22, 2025
Ubiquitin-specific protease 25 improves myocardial ischemia-reperfusion injury by deubiquitinating NLRP3 and negatively regulating NLRP3 inflammasome activity in cardiomyocytes
Bozhi Ye, Diyun Xu, Lingfeng Zhong, et al.
International Immunopharmacology
|
September 18, 2022
Inhibition of MyD88 attenuates angiotensin II-induced hypertensive kidney disease via regulating renal inflammation
Ke Lin, Wu Luo, Na Yang, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 66) with videos related to
Sort By:
Page
of 7
Nature Cardiovascular Research
|
August 28, 2024
Deubiquitinase JOSD2 improves calcium handling and attenuates cardiac hypertrophy and dysfunction by stabilizing SERCA2a in cardiomyocytes
Jibo Han, Zimin Fang, Bingjiang Han, et al.
British Journal of Pharmacology
|
March 31, 2026
The deubiquitinase YOD1 in cardiomyocytes mediates septic cardiomyopathy by deubiquitinating and thus stabilizing the NLRP3 inflammasome
Zhaozheng Zheng, Yingjie Liao, Yucheng Jiang, et al.
ESC Heart Failure
|
January 26, 2021
The prevalence, predictors, and outcomes of spontaneous echocardiographic contrast or left ventricular thrombus in patients with HFrEF
Xiaodong Zhou, Ruiyu Shi, Gaojun Wu, et al.
Theranostics
|
May 8, 2023
OTUD1 promotes pathological cardiac remodeling and heart failure by targeting STAT3 in cardiomyocytes
Mengyang Wang, Xue Han, Tianxiang Yu, et al.
EMBO Molecular Medicine
|
March 10, 2023
Macrophage DCLK1 promotes atherosclerosis via binding to IKKβ and inducing inflammatory responses
Zhuqi Huang, Sirui Shen, Xue Han, et al.
Inflammopharmacology
|
March 27, 2025
Carnosol mitigates Ang II-stimulated vascular injury and oxidative stress by directly binding to FAK and inhibiting its activation
Yucheng Jiang, Zhaozheng Zheng, JunYi Wang, et al.
Acta Pharmaceutica Sinica. B
|
April 4, 2024
Hyperglycemia activates FGFR1 <i>via</i> TLR4/c-Src pathway to induce inflammatory cardiomyopathy in diabetes
Xiong Chen, Jinfu Qian, Shiqi Liang, et al.
Acta Pharmaceutica Sinica. B
|
June 9, 2025
Deubiquitinase USP13 alleviates doxorubicin-induced cardiotoxicity through promoting the autophagy-mediated degradation of STING
Liming Lin, Jibo Han, Diyun Xu, et al.
Clinical and Translational Medicine
|
February 22, 2025
Ubiquitin-specific protease 25 improves myocardial ischemia-reperfusion injury by deubiquitinating NLRP3 and negatively regulating NLRP3 inflammasome activity in cardiomyocytes
Bozhi Ye, Diyun Xu, Lingfeng Zhong, et al.
International Immunopharmacology
|
September 18, 2022
Inhibition of MyD88 attenuates angiotensin II-induced hypertensive kidney disease via regulating renal inflammation
Ke Lin, Wu Luo, Na Yang, et al.
Page
of 7